Thomas F. Newton, M.D.

Studies associated with:
Division Study Number Title Investigator(s) Release Date
DTMC NIDA-CTO-0007 Phase 2, Double-Blind, Placebo-Controlled Trial Of Cabergoline For The Treatment Of Cocaine Dependence Steven Shoptaw, Ph.D., Thomas F. Newton, M.D.
DTMC NIDA-CTO-0004 Assessment Of Potential Interactions Between Intravenous Methamphetamine And Oral Selegiline Thomas F. Newton, M.D.
DTMC NIDA-CTO-0003 Assessment Of Potential Interactions Between Intravenous Cocaine And Tolcapone Thomas F. Newton, M.D.